Search Results Search Sort by RelevanceMost Recent Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Feb 2023 What the COVID-19 Pandemic Teaches Us About Pediatric Iatrogenic Risk Katherine Pumphrey, MD, MHA and Jessica Hart, MD, MHQS Pediatricians have been forced to navigate diagnostic uncertainty, hospital closures, limited staffing, and new infection control guidelines. AMA J Ethics. 2023;25(2):E130-132. doi: 10.1001/amajethics.2023.130. Policy Forum Sep 2022 Roles of Environmental Services Workers’ Wages and Status in Patient Safety David Sine, DBioethics and Lloyd Duplechan This article offers a risk management standpoint on environmental services as a mission-critical function of any health care organization. AMA J Ethics. 2022;24(9):E876-882. doi: 10.1001/amajethics.2022.876. Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503. Policy Forum Oct 2004 The Universal Protocol Dennis S. O'Leary, MD Virtual Mentor. 2004;6(10):456-458. doi: 10.1001/virtualmentor.2004.6.10.pfor1-0410. Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403. Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Feb 2023 What the COVID-19 Pandemic Teaches Us About Pediatric Iatrogenic Risk Katherine Pumphrey, MD, MHA and Jessica Hart, MD, MHQS Pediatricians have been forced to navigate diagnostic uncertainty, hospital closures, limited staffing, and new infection control guidelines. AMA J Ethics. 2023;25(2):E130-132. doi: 10.1001/amajethics.2023.130.
Policy Forum Sep 2022 Roles of Environmental Services Workers’ Wages and Status in Patient Safety David Sine, DBioethics and Lloyd Duplechan This article offers a risk management standpoint on environmental services as a mission-critical function of any health care organization. AMA J Ethics. 2022;24(9):E876-882. doi: 10.1001/amajethics.2022.876.
Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503.
Policy Forum Oct 2004 The Universal Protocol Dennis S. O'Leary, MD Virtual Mentor. 2004;6(10):456-458. doi: 10.1001/virtualmentor.2004.6.10.pfor1-0410.
Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403.
Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609.